Industry welcomes revised medical device marketing code with new disclosure norms
UCMPMD amendment introduces annual reporting, limits on free samples, and stricter compliance measures for India’s MedTech sector
The healthcare industry hails the government’s notification amending the Uniform Code for Marketing Practices in Medical Devices (UCMPMD).
The Ministry of Chemicals and Fertilizers, through Circular 3/2025, has introduced mandatory annual disclosure requirements, simplified reporting formats, and clearer valuation rules for free samples. According to the notification, chief executives or managing directors of medical device companies will now be required to file annual declarations of marketing expenditure within two months of the close of the financial year. For FY25, the deadline has been extended to 30 September 2025.
The amended code caps free evaluation samples at 2 per cent of domestic sales, with valuation recorded at stockist price if manufactured in-house, or purchase price if sourced externally. Companies must also disclose expenditure on samples, CME programmes, event sponsorships, and pre-approvals needed for specialist doctor international travel, lodging, and hospitality, in a newly prescribed annexure format.
In addition, the framework prohibits gifts, cash grants, and personal travel or hospitality benefits to healthcare professionals and their families. Industry associations will be required to retain disclosure data for five years, with stricter penalties for violations.
Rajiv Nath, Forum Coordinator, AiMeD:
“At AiMeD we welcome the Universal Code of Ethical Marketing of Medical Devices and the simplified annual reporting format. The Code ensures ethical and transparent marketing, fostering fair competition and stronger reputations for both domestic and overseas manufacturers. Patients benefit through safer devices, trustworthy information, and freedom from exploitative promotions.”
Pavan Choudary, Chairman, MTaI:
“We have noted the amendments made to the UCMPMD code and are going through the fine print. While the revised framework provides greater clarity for the MedTech industry, it also places weighted responsibility on industry associations to ensure compliance and safeguard members’ data. We have already constituted an Ethics Committee and updated our web portal in line with UCMPMD requirements, and are now gearing up to shoulder the additional responsibilities.”
- Advertisement -